FUSED TETRACYCLIC HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
    5.
    发明公开
    FUSED TETRACYCLIC HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES 审中-公开
    KONDENSIERTE TETRACYCLISCHE UND杂种洋葱VERBINDUNGEN SOWIE VERFAHREN ZUR VERWENDUNG DAVON ZUR BEHANDLUNG VON VIRENERKRANKUNGEN

    公开(公告)号:EP3083634A4

    公开(公告)日:2017-06-07

    申请号:EP14870683

    申请日:2014-12-15

    IPC分类号: C07D493/04 A61P31/12

    摘要: The present invention relates to novel Fused Tetracyclic Heterocyclic Compounds of Formula I: (I), wherein A, A', R2A, R2B, R7, R8, R9, and R10 are defined herein. The compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of infection by HCV and the prophylaxis, treatment, or delay in the onset of disease caused by HCV. The present invention also relates to pharmaceutical compositions comprising at least one Fused Tetracyclic Heterocyclic Compound, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines, and methods of using the Fused Tetracyclic Heterocyclic Compounds for treating or preventing HCV infection in a patient.

    摘要翻译: 本发明涉及式I的新型稠合四环杂环化合物:其中A,A',R2A,R2B,R7,R8,R9和R10如本文所定义。 这些化合物及其药学上可接受的盐可用于预防或治疗由HCV引起的感染和由HCV引起的疾病发作的预防,治疗或延迟。 本发明还涉及药物组合物,其包含至少一种稠合四环杂环化合物,任选地与其他抗病毒剂,免疫调节剂,抗生素或疫苗组合,以及使用稠合四环杂环化合物治疗或预防患者中HCV感染的方法。